NSCLC Patient Derived Xenograft (ADOR) from KERAFAST, INC.

Search, find, compare suppliers for NSCLC Patient Derived Xenograft (ADOR) products.

Edit 
Product NameNSCLC Patient Derived Xenograft (ADOR)
DescriptionSource: Human Lung. Cell type: NSCLC, adenocarcinoma.
Size1 vial (1M cells)
Concentrationn/a
Applicationsn/a
Other Namesn/a
Gene, Accession, CAS #n/a
Catalog #EVC004
Price$438
Order / More InfoNSCLC Patient Derived Xenograft (ADOR) from KERAFAST, INC.
Product Specific References
  1. Booth L, Albers T, Roberts JL, Tavallai M, Poklepovic A, Lebedyeva IO, Dent P.Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to killtumor cells in vitro and in vivo. Oncotarget. 2016 Jun 28;7(26):40398-40417.
KERAFAST, INC.
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com
Profile of KERAFAST, INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.